Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent low level Epstein-Barr virus DNAemia in childhood cancer survivors.
Mahmoud SS, Fukushima T, Shimizu T, Nakao T, Yamaguchi R, Fukushima H, Wada H, Nanmoku T, Sumazaki R. Mahmoud SS, et al. Among authors: fukushima t, fukushima h. Pediatr Hematol Oncol. 2013 Apr;30(3):216-25. doi: 10.3109/08880018.2012.760021. Epub 2013 Jan 17. Pediatr Hematol Oncol. 2013. PMID: 23327678
Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies.
Fukushima H, Fukushima T, Sakai A, Suzuki R, Nakajima-Yamaguchi R, Kobayashi C, Iwabuchi A, Saito M, Yoshimi A, Nakao T, Kato K, Tsuchida M, Takahashi H, Koike K, Kiyokawa N, Noguchi E, Sumazaki R. Fukushima H, et al. Among authors: fukushima t. Leuk Res Treatment. 2013;2013:238528. doi: 10.1155/2013/238528. Epub 2013 Dec 10. Leuk Res Treatment. 2013. PMID: 24386571 Free PMC article.
Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.
Tanaka Y, Manabe A, Fukushima H, Suzuki R, Nakadate H, Kondoh K, Nakamura K, Koh K, Fukushima T, Tsuchida M, Koike K, Kiyokawa N, Noguchi E, Sumazaki R, Komiyama T. Tanaka Y, et al. Among authors: fukushima t, fukushima h. Pharmacogenomics J. 2015 Aug;15(4):380-4. doi: 10.1038/tpj.2014.74. Epub 2014 Nov 18. Pharmacogenomics J. 2015. PMID: 25403995
Preparation of pediatric patients for treatment with proton beam therapy.
Mizumoto M, Oshiro Y, Ayuzawa K, Miyamoto T, Okumura T, Fukushima T, Fukushima H, Ishikawa H, Tsuboi K, Sakurai H. Mizumoto M, et al. Among authors: fukushima t, fukushima h. Radiother Oncol. 2015 Feb;114(2):245-8. doi: 10.1016/j.radonc.2015.01.007. Epub 2015 Jan 22. Radiother Oncol. 2015. PMID: 25620062
Proton beam therapy for pediatric ependymoma.
Mizumoto M, Oshiro Y, Takizawa D, Fukushima T, Fukushima H, Yamamoto T, Muroi A, Okumura T, Tsuboi K, Sakurai H. Mizumoto M, et al. Among authors: fukushima t, fukushima h. Pediatr Int. 2015 Aug;57(4):567-71. doi: 10.1111/ped.12624. Epub 2015 Jun 4. Pediatr Int. 2015. PMID: 25754294
Influence of SLCO1B1 polymorphism on maintenance therapy for childhood leukemia.
Suzuki R, Fukushima H, Noguchi E, Tsuchida M, Kiyokawa N, Koike K, Ma E, Takahashi H, Kobayashi C, Nakajima-Yamaguchi R, Sakai A, Saito M, Iwabuchi A, Kato K, Nakao T, Yoshimi A, Sumazaki R, Fukushima T. Suzuki R, et al. Among authors: fukushima t, fukushima h. Pediatr Int. 2015 Aug;57(4):572-7. doi: 10.1111/ped.12682. Pediatr Int. 2015. PMID: 25939871
Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma.
Fukushima H, Fukushima T, Sakai A, Suzuki R, Kobayashi C, Oshiro Y, Mizumoto M, Hoshino N, Gotoh C, Urita Y, Komuro H, Kaneko M, Sekido N, Masumoto K, Sakurai H, Sumazaki R. Fukushima H, et al. Among authors: fukushima t. Rep Pract Oncol Radiother. 2015 May-Jun;20(3):217-22. doi: 10.1016/j.rpor.2014.12.003. Epub 2015 Jan 9. Rep Pract Oncol Radiother. 2015. PMID: 25949226 Free PMC article.
1,277 results